These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 19502990

  • 61. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.
    Tariq S, Townsend CL, Cortina-Borja M, Duong T, Elford J, Thorne C, Tookey PA, European Collaborative Study, National Study of HIV in Pregnancy Childhood.
    J Acquir Immune Defic Syndr; 2011 Aug 01; 57(4):326-33. PubMed ID: 21499113
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.
    Coovadia A, Hunt G, Abrams EJ, Sherman G, Meyers T, Barry G, Malan E, Marais B, Stehlau R, Ledwaba J, Hammer SM, Morris L, Kuhn L.
    Clin Infect Dis; 2009 Feb 15; 48(4):462-72. PubMed ID: 19133804
    [Abstract] [Full Text] [Related]

  • 67. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
    Kovacs A, Cowles MK, Britto P, Capparelli E, Fowler MG, Moye J, McIntosh K, Rathore MH, Pitt J, Husson RN.
    Pediatr Infect Dis J; 2005 Jun 15; 24(6):503-9. PubMed ID: 15933559
    [Abstract] [Full Text] [Related]

  • 68. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants.
    Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY.
    Antivir Ther; 2004 Apr 15; 9(2):179-85. PubMed ID: 15134179
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy.
    Sripan P, Le Coeur S, Ingsrisawang L, Cressey TR, Bouazza N, Foissac F, Ngo-Giang-Huong N, Traisathit P, Srirompotong U, Ayudhaya OP, Puangsombat A, Jungpipun J, Jittayanun K, Tréluyer JM, Jourdain G, Lallemant M, Urien S.
    Antivir Ther; 2016 Apr 15; 21(5):435-40. PubMed ID: 26492107
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
    Jacob MS, Durairaj A, Vijayakumari J, Srijayanth P, Sivakumar MR.
    Indian J Pathol Microbiol; 2011 Apr 15; 54(2):359-61. PubMed ID: 21623090
    [Abstract] [Full Text] [Related]

  • 75. Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
    Westreich D, Eron J, Behets F, Horst Cv, Van Rie A.
    J Infect Dis; 2007 Mar 15; 195(6):837-46. PubMed ID: 17299714
    [Abstract] [Full Text] [Related]

  • 76. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.
    J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114
    [Abstract] [Full Text] [Related]

  • 77. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D, Cargnel A.
    Scand J Infect Dis Suppl; 2003 Nov 15; 106():70-4. PubMed ID: 15000589
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J, Lambert C, Karita E, Vanhove D, Fischer A, Baurith T, Schmit JC, Schneider F, Hemmer R, Arendt V.
    AIDS Res Hum Retroviruses; 2004 Mar 15; 20(3):279-83. PubMed ID: 15117451
    [Abstract] [Full Text] [Related]

  • 80. Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.
    Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, McIntyre J, Mellors J, Morris L, Coffin J.
    Proc Natl Acad Sci U S A; 2006 May 02; 103(18):7094-9. PubMed ID: 16641095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.